Associated Papers
Whole-Exome Profiling of NSCLC Among African Americans.
Arauz RF et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 2020
Role of cytidine deaminase in toxicity and efficacy of nucleosidic analogs.
Serdjebi C et al.
Expert Opinion on Drug Metabolism & Toxicology, 2015
Human cytidine deaminase: a biochemical characterization of its naturally occurring variants.
Micozzi D et al.
International Journal of Biological Macromolecules, 2014
Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans.
Huang RS et al.
Molecular Cancer Therapeutics, 2008
SNPs in disease gene mapping, medicinal drug development and evolution.
Shastry BS
Journal of Human Genetics, 2007
Pharmacogenetics for individualized cancer chemotherapy.
Efferth T et al.
Pharmacology & Therapeutics, 2005
Predicting drug response and toxicity based on gene polymorphisms.
Robert J et al.
Critical Reviews in Oncology/hematology, 2005
A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity.
Yue L et al.
Pharmacogenetics, 2003
Select a paper to view details